DiaMedica Therapeutics Inc. (DMAC)

CIK 1401040 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for DiaMedica Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Aug 12, 202640001760123-26-000004
Aug 11, 2026S-80001437749-26-026864
Aug 10, 202610-Q0001437749-26-026792
Aug 10, 20268-K0001437749-26-026790
Jun 3, 202640001490476-26-000002
Jun 3, 202640001759855-26-000004
Jun 3, 202640001759822-26-000004
Jun 3, 202640001872863-26-000004
Jun 3, 202640001376847-26-000002
Jun 3, 202640001341125-26-000002
Jun 3, 202640001643127-26-000002
Jun 3, 202640001451038-26-000002
Jun 3, 202640001760123-26-000002
May 21, 20268-K0001437749-26-018106
May 6, 202610-Q0001437749-26-015220
May 6, 20268-K0001437749-26-015218
Apr 1, 2026DEF 14A0001437749-26-010879
Apr 1, 2026ARS0001437749-26-010881
Apr 1, 2026DEFA14A0001437749-26-010880
Mar 31, 20268-K0001437749-26-010409
Mar 30, 202610-K0001437749-26-010342
Feb 17, 2026SCHEDULE 13G/A0000919574-26-001133
Feb 17, 2026SCHEDULE 13G/A0000945621-26-000352
Feb 6, 2026SCHEDULE 13G/A0001104659-26-011569
Jan 6, 202640001759822-26-000002